GKB Ophthalmics

{
  "main_header": {
    "sid": 360373,
    "name": "GKB Ophthalmics",
    "stock_name": "GKB Ophthalmics",
    "full_name": "GKB Ophthalmics Ltd",
    "name_url": "stocks-analysis/gkb-ophthalmics",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "59.90",
    "chg": -0.45,
    "chgp": "-0.75%",
    "dir": -1,
    "prev_price": "60.35",
    "mcapval": "30.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533212,
    "symbol": "GKB",
    "ind_name": "Healthcare Services",
    "ind_code": 31,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE265D01015",
    "curr_date": "Jul 07, 01:24 PM",
    "curr_time": "13:37 PM",
    "last_traded_at": "Jul 07, 01:24 PM IST",
    "bse_nse_vol": "1.55 k",
    "exc_status": "Active",
    "traded_date": "Jul 07, 2026",
    "traded_date_str": "2026 07 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "GKB Ophthalmics Downgraded to Sell Amid Mixed Financials and Technical Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-downgraded-to-sell-amid-mixed-financials-and-technical-weakness-4091706",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GKBOphthalmicsL_mojoScore_4091706.png",
        "date": "2026-07-07 08:34:40",
        "description": "GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 July 2026, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent positive quarterly results, the company’s long-term fundamentals and technical trends have deteriorated, prompting a reassessment of its outlook within the healthcare services sector."
      },
      {
        "title": "GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-upgraded-to-hold-on-improved-technicals-and-financial-performance-4080989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GKBOphthalmicsL_mojoScore_4080989.png",
        "date": "2026-07-01 08:12:36",
        "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 30 June 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, valuation metrics, and evolving market trends have collectively influenced this reassessment, signalling cautious optimism among investors despite lingering long-term challenges."
      },
      {
        "title": "GKB Ophthalmics Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4068372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GKBOphthalmicsL_mojoScore_4068372.png",
        "date": "2026-06-23 08:28:32",
        "description": "GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 22 June 2026, reflecting a complex interplay of deteriorating technical indicators, valuation appeal, and mixed financial trends. Despite recent positive quarterly earnings, the company’s long-term fundamentals and technical outlook have weakened, prompting a reassessment of its investment potential within the healthcare services sector."
      },
      {
        "title": "GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-upgraded-to-hold-on-improved-technicals-and-financial-performance-4055373",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GKBOphthalmicsL_mojoScore_4055373.png",
        "date": "2026-06-16 08:29:16",
        "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 15 Jun 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, combined with a shift in market sentiment, has prompted analysts to revise their outlook, signalling cautious optimism for investors in this micro-cap healthcare services stock."
      },
      {
        "title": "GKB Ophthalmics Declines 2.71% Despite Valuation Upgrade: 4 Key Factors This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-declines-271-despite-valuation-upgrade-4-key-factors-this-week-4052974",
        "imagepath": "",
        "date": "2026-06-14 12:01:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Upgrade to Hold rating by MarketsMOJO on improved valuation and financial metrics</p>\n                    <p><strong>1 June:</strong> Valuation parameters shift from risky to very attractive, signalling renewed price appeal</p>\n                    <p><strong>3 June:</strong> Sharp rebound with a 4.94% gain amid mixed market conditions</p>\n                    <p><strong>5 June:</strong> Week closes lower at Rs.62.00, down 4.38% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.63.73</div></div>\n                    <div class=\"sta..."
      },
      {
        "title": "GKB Ophthalmics Ltd Downgraded to Sell Amid Mixed Financial Signals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-downgraded-to-sell-amid-mixed-financial-signals-and-weak-fundamentals-4040459",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GKBOphthalmicsL_mojoScore_4040459.png",
        "date": "2026-06-09 08:36:20",
        "description": "GKB Ophthalmics Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 8 June 2026, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent positive earnings growth and attractive valuation multiples, the company’s weak long-term fundamentals and persistent underperformance against benchmarks have prompted a cautious stance."
      },
      {
        "title": "GKB Ophthalmics Ltd Upgraded to Hold on Improved Valuation and Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-upgraded-to-hold-on-improved-valuation-and-financial-trends-4025548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GKBOphthalmicsL_mojoScore_4025548.png",
        "date": "2026-06-01 08:11:28",
        "description": "GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 29 May 2026, reflecting a marked improvement in valuation metrics and financial performance despite ongoing challenges in long-term fundamentals and market returns. The company’s mojo score has risen to 58.0, signalling a more balanced outlook for investors amid a micro-cap classification and a recent share price decline of 1.95%."
      },
      {
        "title": "GKB Ophthalmics Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-ltd-valuation-shifts-signal-renewed-price-attractiveness-4025130",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GKBOphthalmicsL_valuationdot_4025130.png",
        "date": "2026-06-01 08:01:56",
        "description": "GKB Ophthalmics Ltd has witnessed a significant improvement in its valuation parameters, transitioning from a risky to a very attractive investment proposition. With a current price of ₹63.73 and a micro-cap market classification, the healthcare services company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to historical levels and peer averages, prompting an upgrade in its Mojo Grade from Sell to Hold as of 29 May 2026."
      },
      {
        "title": "Are GKB Ophthalmics Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gkb-ophthalmics-ltd-latest-results-good-or-bad-4021826",
        "imagepath": "",
        "date": "2026-05-29 19:41:33",
        "description": "GKB Ophthalmics Ltd's latest financial results for the quarter ended March 2026 reveal significant operational challenges. The company reported consolidated net sales of ₹29.79 crores, reflecting a notable decline of 47.54% quarter-on-quarter and a year-on-year decrease of 3.97%. This marks the lowest quarterly revenue in the past seven quarters, indicating potential issues with order execution and customer retention.\n\nDespite the revenue downturn, GKB Ophthalmics achieved a consolidated net profit of ₹0.19 crores, a recovery from losses in previous quarters. However, this profit represents a sharp decline of 56.82% from the previous quarter and a staggering drop of 105.35% year-on-year, highlighting the volatility in profitability.\n\nThe operating margin, excluding other income, improved to 10.44%, the highest in seven quarters, suggesting some progress in cost management and operational efficiency. However..."
      }
    ],
    "total": 84,
    "sid": "360373",
    "stock_news_url": "https://www.marketsmojo.com/news/gkb-ophthalmics-360373"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
      "datetime": "30-Jun-2026",
      "details": "Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI ( Prohibition of Insider TRading ) Regulations 2015 (PIT Regulation 2015) intimation be and is hereby given that Krishna Gopal Gupta and Son(HUF) has purchased 1016 equity share aggregating to Rs. 64801.77/- from 08.06.2026 to 17.06.2026 on market which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations 2015. However as a good Corporate governance measure the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations 2015 is enclosed herewith. Please acknowledge and take the same on record.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Pursuant to SEBI (Prohibition of Insider Trading ) Regulations 2015 as amended from time to time The Trading Window for dealing /Trading in the shares of the Company shall remain closed from July 012026 till the completion of 48 hours after the declaration of the financial results of the Company for the quarter ended June 30 2026. Accordingly all the Promoters Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company during the period of closure of Trading Window. Further the date of Board Meeting at which the said results will be considered shall be intimated in due course of time.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Please find enclosed copies of newspaper cuttings of the extract of statement of audited Standalone and Consolidated Financial Results for the year ended March 31 2026 published in Free Press Journal (Mumbai Edition) and on Pudhari (Marathi) dated May 29 2026. Please acknowledge receipt.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10",
          "dt": "2010-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

GKB Ophthalmics Downgraded to Sell Amid Mixed Financials and Technical Weakness

2026-07-07 08:34:40

GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 July 2026, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent positive quarterly results, the company’s long-term fundamentals and technical trends have deteriorated, prompting a reassessment of its outlook within the healthcare services sector.

Read full news article

GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance

2026-07-01 08:12:36

GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 30 June 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, valuation metrics, and evolving market trends have collectively influenced this reassessment, signalling cautious optimism among investors despite lingering long-term challenges.

Read full news article

GKB Ophthalmics Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-06-23 08:28:32

GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell as of 22 June 2026, reflecting a complex interplay of deteriorating technical indicators, valuation appeal, and mixed financial trends. Despite recent positive quarterly earnings, the company’s long-term fundamentals and technical outlook have weakened, prompting a reassessment of its investment potential within the healthcare services sector.

Read full news article

GKB Ophthalmics Ltd Upgraded to Hold on Improved Technicals and Financial Performance

2026-06-16 08:29:16

GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 15 Jun 2026, reflecting a notable improvement in its technical indicators and financial results. The company’s recent quarterly performance, combined with a shift in market sentiment, has prompted analysts to revise their outlook, signalling cautious optimism for investors in this micro-cap healthcare services stock.

Read full news article

GKB Ophthalmics Declines 2.71% Despite Valuation Upgrade: 4 Key Factors This Week

2026-06-14 12:01:45

Key Events This Week

1 June: Upgrade to Hold rating by MarketsMOJO on improved valuation and financial metrics

1 June: Valuation parameters shift from risky to very attractive, signalling renewed price appeal

3 June: Sharp rebound with a 4.94% gain amid mixed market conditions

5 June: Week closes lower at Rs.62.00, down 4.38% on the day

Week Open

Rs.63.73

Read full news article

GKB Ophthalmics Ltd Downgraded to Sell Amid Mixed Financial Signals and Weak Fundamentals

2026-06-09 08:36:20

GKB Ophthalmics Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 8 June 2026, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent positive earnings growth and attractive valuation multiples, the company’s weak long-term fundamentals and persistent underperformance against benchmarks have prompted a cautious stance.

Read full news article

GKB Ophthalmics Ltd Upgraded to Hold on Improved Valuation and Financial Trends

2026-06-01 08:11:28

GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold as of 29 May 2026, reflecting a marked improvement in valuation metrics and financial performance despite ongoing challenges in long-term fundamentals and market returns. The company’s mojo score has risen to 58.0, signalling a more balanced outlook for investors amid a micro-cap classification and a recent share price decline of 1.95%.

Read full news article

GKB Ophthalmics Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-01 08:01:56

GKB Ophthalmics Ltd has witnessed a significant improvement in its valuation parameters, transitioning from a risky to a very attractive investment proposition. With a current price of ₹63.73 and a micro-cap market classification, the healthcare services company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to historical levels and peer averages, prompting an upgrade in its Mojo Grade from Sell to Hold as of 29 May 2026.

Read full news article

Are GKB Ophthalmics Ltd latest results good or bad?

2026-05-29 19:41:33

GKB Ophthalmics Ltd's latest financial results for the quarter ended March 2026 reveal significant operational challenges. The company reported consolidated net sales of ₹29.79 crores, reflecting a notable decline of 47.54% quarter-on-quarter and a year-on-year decrease of 3.97%. This marks the lowest quarterly revenue in the past seven quarters, indicating potential issues with order execution and customer retention. Despite the revenue downturn, GKB Ophthalmics achieved a consolidated net profit of ₹0.19 crores, a recovery from losses in previous quarters. However, this profit represents a sharp decline of 56.82% from the previous quarter and a staggering drop of 105.35% year-on-year, highlighting the volatility in profitability. The operating margin, excluding other income, improved to 10.44%, the highest in seven quarters, suggesting some progress in cost management and operational efficiency. However...

Read full news article

View All News